Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men

Fertility and Sterility

Volumn 65, Issue 4, 1996, Pages 821-829

  Griffin, P D ^a   Aribarg, A ^a   Gui yuan, Z ^a   Jian, C ^a   Guo zhu, L ^a   Anderson, R A ^a   Swerdloff, R S ^a   Wu, F C W ^a   Baker, H W G ^a   Xing hai, W ^a   Soufir, J C ^a   Paulsen, C A ^a   Ng, S C ^a   Gottlieb, C ^a   Handelsman, D J ^a   Conway, A J ^a   Resch, B ^a   Szollosi, J ^a   Farley, T M M ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

azoospermia; contraception; Multicenter study; oligozoospermia; spermatogenic suppression; testosterone enanthate

Indexed keywords

TESTOSTERONE;

ADULT; ARTICLE; AZOOSPERMIA; DRUG EFFICACY; GROWTH INHIBITION; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGOSPERMIA; PRIORITY JOURNAL; SPERMATOZOON MATURATION; TREATMENT OUTCOME;

EID: 0029960780     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58221-1     Document Type: Article

References (29)

1. United Nations World contraceptive use 1994 1994 UN Department for Economic and Social Information and Policy Analysis, Population Division (ST/ESA/SER.A/143) New York
2. E.M. Wallace R.J. Aitken F.C.W. Wu Residual sperm function in oligozoospermia induced by testosterone enanthate administered as a potential steroid male contraceptive Int J Androl 15 1992 416 424
3. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men Lancet 336 1990 955 959
4. D.J. Patanelli Hormonal control of male fertility 1978 US Department of Health Education and Welfare, Publication number (NIH) 78-1097 Washington (DC)
5. R.A. Hatcher D. Kowal F.J. Guest J. Trussell F.H. Stewart G.K. Stewart Contraceptive technology: international edition 1989 Printed Matter, Inc. Atlanta
6. World Health Organization WHO laboratory manual for the examination of human semen and semen-cervical mucus interaction 2nd edition 1987 Cambridge University Press Cambridge
7. E. Nieschlag H.M. Behre G.F. Weinbauer Hormonal male contraception: a real chance? E. Nieschlag U.F. Habenicht Spermatogenesis, fertilization, contraception: molecular, cellular and endocrine events in male reproduction 1992 Springer-Verlag Berlin 477 501
8. S.B. Schearer F. Alvarez-Sanchez J. Anselmo P. Brenner E. Coutinho A. Latham-Faundes Hormonal contraception for men Int J Androl 2 1978 680 712 (Suppl)
9. D.J. Handelsman T.M.M. Farley A. Peregoudov G.M.H. Waites the World Health Organization Task Force on Methods for the Regulation of Male Fertility. Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men Fertil Steril 63 1995 125 133
10. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men Fertil Steril 60 1993 1062 1068
11. K. Ringheim Evidence for the acceptability of an injectable hormonal method for men Int Fam Plann Persp 21 1995 75 80
12. U.A. Knuth H. Behre L. Belkien H. Bents E. Nieschlag Clinical trial of 19-nortestosterone hexoxyphenylpropionate (Anadur) for male fertility regulation Fertil Steril 44 1985 814 821
13. D.J. Handelsman A.J. Conway L.M. Boylan Suppression of human spermatogenesis by testosterone implants in man J Clin Endocrinol Metab 75 1992 1326 1332
14. C.J. Bagatell A.M. Matsumoto R.B. Christensen J.E. Rivier W.J. Bremner Comparison of a gonadotropin-releasing hormone antagonist plus testosterone (T) versus T alone as a potential male contraceptive J Clin Endocrinol Metab 77 1993 427 432
15. P. Jouannet B. Ducot D. Feneux A. Spira Male factors and the likelihood of pregnancy in infertile couples. I Study of sperm characteristics Int J Androl 11 1988 379 394
16. A. Barfield J. Melo E. Coutinho F. Alvarez-Sanchez A. Faundes V. Brache Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters Contraception 20 1979 121 127
17. F.C.W. Wu T.M.M. Farley A. Peregoudov G.M.H. Waites the WHO Task Force on Methods for the Regulation of Male Fertility. Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study Fertil Steril 65 1996 626 636
18. E.M. Wallace S.D. Pye S.R. Wild F.C.W. Wu Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception Int J Androl 16 1993 35 40
19. H.M. Behre J. Bohmeyer E. Nieschlag Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls Clin Endocrinol (Oxf) 40 1994 341 349
20. S.R. Plymate R.S. Swerdloff Androgens, lipids and cardiovascular risk Ann Intern Med 117 1992 871 872
21. K.E. Friedl C.J. Hannan R.E. Jones S.R. Plymate High-density lipoprotein cholesterol is not decreased if an aromatisable androgen is administered Metabolism 39 1990 69 74
22. C.J. Bagatell J.R. Heiman A.M. Matsumoto J.E. Rivier W.J. Bremner Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men J Clin Endocrinol Metab 79 1994 561 567
23. R.A. Anderson E.M. Wallace F.C.W. Wu Effect of testosterone enanthate on serum lipoprotein in man Contraception 52 1995 115 119
24. R.A. Anderson J. Bancroft F.C.W. Wu The effects of exogenous testosterone on sexuality and mood of normal men J Clin Endocrinol Metab 75 1992 1503 1507
25. I. Huhtaniemi Anabolic-androgenic steroids—a double-edged sword? Int J Androl 17 1994 57 62
26. N.R. Young H.W.G. Baker G. Liu E. Seeman Body composition and muscle strength in health men receiving testosterone enanthate for contraception J Clin Endocrinol Metab 77 1993 1028 1032
27. H.M. Behre S. Baus S. Kliesch C. Keck M. Simoni E. Nieschlag Potential of testosterone buciclate for male contraception: endocrinological differences between responders and non-re-sponders J Clin Endocrinol Metab 80 1995 2394 2403
28. S. Bhasin R.S. Swerdloff B. Steiner M.A. Peterson T. Meridores M. Galmirini A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men J Clin Endocrinol Metab 74 1992 75 83
29. L. Mastrioanni P.J. Donaldson T.T. Kane Development of contraceptives—obstacles and opportunities N Engl J Med 322 1990 482 484